EPO Research Guide

Full name: Erythropoietin (EPO)

A glycoprotein hormone that stimulates red blood cell production. Medically used for anemia, it is also notorious as a banned endurance-enhancing agent. Included here for educational reference on its mechanism and significant risks.

How EPO Works

Binds erythropoietin receptors on bone marrow progenitor cells, stimulating proliferation and maturation of red blood cells. More red cells raise oxygen-carrying capacity, but also thicken the blood.

Dosing Protocol

• Typical dose: Prescription-only, condition-specific
• Frequency: Per medical protocol
• Duration: Per medical protocol
• Route: Subcutaneous or IV injection

Reported Benefits

• Increases red blood cell production
• Treats anemia (medical use)
• Raises oxygen-carrying capacity

Potential Side Effects

• Blood clots/thrombosis
• Stroke and heart attack risk
• Hypertension
• Increased blood viscosity
• Banned in competitive sport

Research Citations

1. Erythropoietin in anemia management (2018) - Effectively raised hemoglobin in anemia of chronic kidney disease, with dose-dependent cardiovascular risk.

Related Muscle Growth Compounds

• Follistatin 344 - Full Profile
• ACE-031 - Full Profile
• IGF-1 LR3 - Full Profile
• MGF (Mechano Growth Factor) - Full Profile
• Myostatin Inhibitor - Full Profile
• LGD-4033 - Full Profile

View full EPO profile with 3D molecule viewer →